Beta blockade as adjunctive breast cancer therapy: A review

被引：25
作者：
Phadke, Sneha [1 ]
Clamon, Gerald [1 ]
机构：
[1] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Hematol Oncol & Blood & Marrow Transplantat, 200 Hawkins Dr, Iowa City, IA 52242 USA
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2019年 / 138卷
关键词：
Propranolol; Breast cancer; Beta adrenergic receptors; Beta blocker; TUMOR-GROWTH; ADRENERGIC-STIMULATION; CARDIAC DYSFUNCTION; T-LYMPHOCYTE; IN-VITRO; BLOCKERS; PROPRANOLOL; CHEMOTHERAPY; ANGIOSARCOMA; RECURRENCE;
D O I：
10.1016/j.critrevonc.2019.04.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Pre-clinical data has shown that beta adrenergic stimulation can affect the development and progression of many types of cancer. The use of beta blockers as an anti-neoplastic therapy has been studied in retrospective trials and observational trials, but no definitive conclusions about efficacy have been made. Within the realm of breast cancer, significant advances in therapy have led to improved survival outcomes, yet there is room for improvement. Beta adrenergic blockade may prove an effective adjunct to standard breast cancer therapy, with little associated toxicity. This article provides a review of the published literature on beta blockade as an adjunctive cancer therapy, with a focus on breast cancer.
引用
收藏
页码：173 / 177
页数：5
相关论文
共 49 条
[1]  
Amaya Clarissa N, 2018, Oncoscience, V5, P109, DOI 10.18632/oncoscience.413
[2]   Beta Blockers and Breast Cancer Mortality: A Population-Based Study [J].
Barron, Thomas I. ;
Connolly, Roisin M. ;
Sharp, Linda ;
Bennett, Kathleen ;
Visvanathan, Kala .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) :2635-2644
[3]   Perioperative use of β-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis [J].
Benish, Marganit ;
Bartal, Inbal ;
Goldfarb, Yael ;
Levi, Ben ;
Avraham, Roi ;
Raz, Amiram ;
Ben-Eliyahu, Shamgar .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (07) :2042-2052
[4]   Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women [J].
Botteri, Edoardo ;
Munzone, Elisabetta ;
Rotmensz, Nicole ;
Cipolla, Carlo ;
De Giorgi, Vincenzo ;
Santillo, Barbara ;
Zanelotti, Arnaldo ;
Adamoli, Laura ;
Colleoni, Marco ;
Viale, Giuseppe ;
Goldhirsch, Aron ;
Gandini, Sara .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (03) :567-575
[5]   RADIATION-INDUCED ANGIOSARCOMA OF THE BREAST - CASE-REPORT AND REVIEW OF THE LITERATURE [J].
BUATTI, JM ;
HARARI, PM ;
LEIGH, BR ;
CASSADY, JR .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (05) :444-447
[6]   Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts [J].
Cardwell, Chris R. ;
Pottegard, Anton ;
Vaes, Evelien ;
Garmo, Hans ;
Murray, Liam J. ;
Brown, Chris ;
Vissers, Pauline A. J. ;
O'Rorke, Michael ;
Visvanathan, Kala ;
Cronin-Fenton, Deirdre ;
De Schutter, Harlinde ;
Lambe, Mats ;
Powe, Des G. ;
van Herk-Sukel, Myrthe P. P. ;
Gavin, Anna ;
Friis, Soren ;
Sharp, Linda ;
Bennett, Kathleen .
BREAST CANCER RESEARCH, 2016, 18
[7]   β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis [J].
Childers, W. Kurtis ;
Hollenbeak, Christopher S. ;
Cheriyath, Pramil .
CLINICAL BREAST CANCER, 2015, 15 (06) :426-431
[8]   β-Adrenergic receptor expression in vascular tumors [J].
Chisholm, Karen M. ;
Chang, Kay W. ;
Truong, Mai T. ;
Kwok, Shirley ;
West, Rob B. ;
Heerema-McKenney, Amy E. .
MODERN PATHOLOGY, 2012, 25 (11) :1446-1451
[9]   Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade [J].
Chow, William ;
Amaya, Clarissa N. ;
Rains, Steven ;
Chow, Michael ;
Dickerson, Erin B. ;
Bryan, Brad A. .
JAMA DERMATOLOGY, 2015, 151 (11) :1226-1229
[10]   Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade [J].
Choy, Cecilia ;
Raytis, John L. ;
Smith, David D. ;
Duenas, Matthew ;
Neman, Josh ;
Jandial, Rahul ;
Lew, Michael W. .
ONCOLOGY REPORTS, 2016, 35 (06) :3135-3142
12345